80
Views
3
CrossRef citations to date
0
Altmetric
Original

Nitrogen Mustard Therapy in Hodgkin's Disease, Lympho-Reticulosarcomatosis and Lymphatic Leukaemia

Pages 461-468 | Published online: 14 Dec 2010

References

  • ApThomas, M. I. R. and Cullumbine, H. (1947) Nitrogen mustards in Hodgkin's disease. Report on 21 cases and 4 of other reticuloses. Lancet, 1, p. 899.
  • Bichel, J. (1948) Chemotherapy in leukemia, Hodgkin's disease, and allied disorders. Acta radiol, 30, p. 49.
  • Craver, L. F. (1948) The nitrogen mustards. Clinical use. Radiology, 50, p. 486.
  • Frisk, A. R. and Hultberg, S. (1948) Kvavesenapsgasbehandling av lymfogranulomatosis maligna. (Swedish). Svenska Lakartidn, 45, p. 685.
  • Gilman, A. and Philips, F. S. (1946) The biological actions and therapeutic applications of the beta-chloroethyl amines and sulfides. Science, 103, p. 409.
  • Goodman, L. S. , Wintrobe, M. M. , Dameshek, W. , Goodman, M. J. , Gilman, A. and McLennan, M. T. (1946) Nitrogen mustard therapy. J. A. M. A, 132, p. 126.
  • Iversen, K. and Kjerulf-Jensen, K. (1948) Kvælstofsennepsgas ved lymfogranulomatosis maligna, polycytaemia og myelomatosis. (Danish). Nord. med, 38, p. 1248.
  • Jacobson, L. O. , Spurr, C. L. , Barron, E. S. G. , Smith, T. , Lushbaugh, C. and Dick, G. F. (1946) Nitrogen mustard therapy. J. A. M. A, 132, p. 263.
  • Rhoads, C. P. (1946) Nitrogen mustards in the treatment of neoplastic disease. J. A. M. A, 131, p. 656.
  • Sherry, M. (1948) Nitrogen mustards in the treatment of Hodgkin's disease and lymphosarcoma. South. M. J, 41, p. 118.
  • Spurr, C. L. , Jacobson, L. O. , Smith, T. R. and Barron, E. S. G. (1947) The clinical application of a nitrogen mustard compound methyl bis (beta-chloroethyl) amine to the treatment of neoplastic disorders of the hemopoietic system. Cancer Research, p. 51.
  • Videbæk, A. (1949) On the use of nitrogen mustard as a therapeutic agent. Acta med. Scandinav, 135, p. 47.
  • Wintrobe, M. M. , Huguley Jr., C. M. , McLennan, M. T. and de Lima, L. P. C. (1947) Nitrogen mustard as therapeutic agent for Hodgkin's disease, lymphosarcoma and Leukemia. Ann. Int. Med, 27, p. 529.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.